Leaderboards/ASO

ASO

Last updated May 19, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
John C. Means
Children's Mercy Hospital
117 cit.
2
Scarlett J. Barker
Denali Therapeutics (United States)
111 cit.
3
Leslie Cho
Cleveland Clinic
93 cit.
4
Xun He
University of Electronic Science and Technology of China
82 cit.
5
Charlotte J. Sumner
Johns Hopkins University
69 cit.
6
Lara Falcucci
Max Planck Institute for Heart and Lung Research
69 cit.
7
Yuchun Ren
Shandong Normal University
64 cit.
8
Writakshi Mandal
Indian Institute of Science Education and Research Pune
57 cit.
9
Metin Katlav
Bitlis Eren University
55 cit.
10
Michael P. Moazami
University of Massachusetts Chan Medical School
50 cit.

Rising Stars Papers

1
Rapid and scalable personalized ASO screening in patient-derived organoids
Nature|2025
38 cit.
2
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Science Translational Medicine|2024
110 cit.
3
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
American Heart Journal|2025
92 cit.
4
Structural evolution and self-reconstruction of nickel hexacyanoferrate Prussian blue analogues for long-lasting ampere-current seawater oxidation
Nano Today|2024
81 cit.
5
The expanding application of antisense oligonucleotides to neurodegenerative diseases
Journal of Clinical Investigation|2024
22 cit.
6
Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy
Nature|2025
22 cit.
7
Metal-organic frameworks (MOFs) and related other advanced porous materials for sequestration of heavy metal-based toxic oxo-pollutants from water
Coordination Chemistry Reviews|2024
56 cit.
8
Improved forecasting of the compressive strength of ultra‐high‐performance concrete (<scp>UHPC</scp>) via the <scp>CatBoost</scp> model optimized with different algorithms
Structural Concrete|2024
54 cit.
9
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous system
Molecular Therapy|2024
24 cit.
10
Efficient DC motor speed control using a novel multi-stage FOPD(1 + PI) controller optimized by the Pelican optimization algorithm
Scientific Reports|2024
49 cit.

Rising Stars Reagents

Coming soon

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Sergiu P. Pașca
Neurosciences Institute
149 cit.
2
Timothy W. Yu
Broad Institute
147 cit.
3
Arthur A. Levin
Fleet Science Center
125 cit.
4
Bo Tang
Shandong Normal University
124 cit.
5
Greg L. Hura
Lawrence Berkeley National Laboratory
81 cit.
6
Dev P. Arya
Nubad (United States)
52 cit.
7
Joel D. Richter
University of Massachusetts Chan Medical School
51 cit.
8
Ludo Van Den Bosch
VIB-KU Leuven Center for Brain & Disease Research
42 cit.
9
Hua Lu
Peking University
38 cit.
10
Rakesh N. Veedu
Perron Institute for Neurological and Translational Science
32 cit.

Emerging Leaders Papers

1
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nature|2024
99 cit.
2
A framework for individualized splice-switching oligonucleotide therapy
Nature|2023
147 cit.
3
Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)
Nucleic Acids Research|2023
125 cit.
4
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
Communications Medicine|2024
237 cit.
5
Carbon Oxyanion Self‐Transformation on NiFe Oxalates Enables Long‐Term Ampere‐Level Current Density Seawater Oxidation
Angewandte Chemie International Edition|2023
203 cit.
6
Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering
ACS Nano|2023
89 cit.
7
A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient
Scientific Reports|2024
116 cit.
8
Antisense oligonucleotide rescue of CGG expansion–dependent <i>FMR1</i> mis-splicing in fragile X syndrome restores FMRP
Proceedings of the National Academy of Sciences|2023
51 cit.
9
The sense of antisense therapies in ALS
Trends in Molecular Medicine|2024
47 cit.
10
Organ/Cell-Selective Intracellular Delivery of Biologics via <i>N</i>-Acetylated Galactosamine-Functionalized Polydisulfide Conjugates
Journal of the American Chemical Society|2024
38 cit.

Emerging Leaders Reagents

Coming soon

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Brett P. Monia
Ionis Pharmaceuticals (United States)
6.2k cit.
2
Adrian R. Krainer
Cold Spring Harbor Laboratory
3.4k cit.
3
Anna Mae Diehl
Duke Medical Center
2k cit.
4
Punit P. Seth
Ionis Pharmaceuticals (United States)
1.8k cit.
5
Aaron D. Gitler
Stanford University
1.7k cit.
6
John Ravits
Unknown
1.7k cit.
7
Christine Oliver
Unknown
1.6k cit.
8
Sven Diederichs
German Cancer Research Center
1.6k cit.
9
Frank Rigo
Unknown
1.6k cit.
10
Dianne K. Newman
California Institute of Technology
1.5k cit.

All-Time Leaders Papers

1
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Cell Metabolism|2006
2.1k cit.
2
Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes
Nature|1986
1.8k cit.
3
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Nature|2011
738 cit.
4
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Hepatology|2007
999 cit.
5
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice
Nucleic Acids Research|2014
587 cit.
6
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Nature|2017
578 cit.
7
Targeted degradation of sense and antisense <i>C9orf72</i> RNA foci as therapy for ALS and frontotemporal degeneration
Proceedings of the National Academy of Sciences|2013
554 cit.
8
Institutional Linkages and Organizational Mortality
Administrative Science Quarterly|1991
1.6k cit.
9
The Noncoding RNA <i>MALAT1</i> Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Cancer Research|2012
1.6k cit.
10
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Nature|2014
522 cit.

All-Time Leaders Reagents

Coming soon

Indexing ASO Reagents

Citation data for reagents in this field is currently compiling.